Stratos Wealth Partners LTD. Sells 612 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stratos Wealth Partners LTD. cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,381 shares of the medical equipment provider's stock after selling 612 shares during the quarter. Stratos Wealth Partners LTD.'s holdings in Intuitive Surgical were worth $8,608,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $25,000. Chilton Capital Management LLC grew its position in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 43 shares during the last quarter. Parvin Asset Management LLC purchased a new position in Intuitive Surgical during the 4th quarter worth $26,000. Global Financial Private Client LLC grew its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares during the last quarter. Finally, Elite Financial Inc. purchased a new position in Intuitive Surgical during the 1st quarter worth $26,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president owned 2,245 shares in the company, valued at approximately $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $13.99 during trading hours on Friday, hitting $512.06. 2,951,229 shares of the stock were exchanged, compared to its average volume of 1,682,083. The stock has a market capitalization of $183.53 billion, a P/E ratio of 75.08, a P/E/G ratio of 5.43 and a beta of 1.64. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The business's 50-day moving average is $537.85 and its two-hundred day moving average is $536.68.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter last year, the business posted $1.50 earnings per share. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research reports. Royal Bank Of Canada lowered their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Barclays lowered their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their price target for the company from $515.00 to $440.00 in a report on Monday, June 9th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $592.59.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.